v2.4.0.6
Consolidated Statements Of Changes In Equity (USD $)
In Millions, unless otherwise specified
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income
Retained Earnings
Noncontrolling Interest
Balance at Jan. 30, 2010 $ 2,723.0 $ 0.2 $ 1,210.5 $ 114.7 $ 1,397.8 $ (0.2)
Balance (in shares) at Jan. 30, 2010   158.7        
Comprehensive income (loss):            
Net income (loss) for the 52 weeks ended January 29, 2011, January 28, 2012 and 53 weeks ended February 2, 2013 406.8       408.0 (1.2)
Foreign currency translation 47.8     47.8    
Total comprehensive income (loss) 454.6          
Stock-based compensation 29.5   29.5      
Purchase of treasury stock (in shares)   (17.1)        
Purchase of treasury stock (338.6) (0.1) (338.5)      
Exercise of employee stock options and issuance of shares upon vesting of restricted stock grants (including tax benefit of $18.7, $2.1 and $2.0 for the 52 weeks ended January 29, 2011, January 28, 2012 and 53 weeks ended February 2, 2013 respectively) (in shares)   4.4        
Exercise of employee stock options and issuance of shares upon vesting of restricted stock grants (including tax benefit of $18.7, $2.1 and $2.0 for the 52 weeks ended January 29, 2011, January 28, 2012 and 53 weeks ended February 2, 2013 respectively) 27.4   27.4      
Balance at Jan. 29, 2011 2,895.9 0.1 928.9 162.5 1,805.8 (1.4)
Balance (in shares) at Jan. 29, 2011   146.0        
Purchase of subsidiary shares from noncontrolling interest (0.1)   (1.1)     1.0
Comprehensive income (loss):            
Net income (loss) for the 52 weeks ended January 29, 2011, January 28, 2012 and 53 weeks ended February 2, 2013 338.5       339.9 (1.4)
Foreign currency translation 7.1     7.2   (0.1)
Total comprehensive income (loss) 345.6          
Stock-based compensation 18.8   18.8      
Purchase of treasury stock (in shares)   (11.2)        
Purchase of treasury stock (240.2)   (240.2)      
Exercise of employee stock options and issuance of shares upon vesting of restricted stock grants (including tax benefit of $18.7, $2.1 and $2.0 for the 52 weeks ended January 29, 2011, January 28, 2012 and 53 weeks ended February 2, 2013 respectively) (in shares)   2.0        
Exercise of employee stock options and issuance of shares upon vesting of restricted stock grants (including tax benefit of $18.7, $2.1 and $2.0 for the 52 weeks ended January 29, 2011, January 28, 2012 and 53 weeks ended February 2, 2013 respectively) 20.2   20.2      
Balance at Jan. 28, 2012 3,040.2 0.1 726.6 169.7 2,145.7 (1.9)
Balance (in shares) at Jan. 28, 2012   136.8        
Purchase of subsidiary shares from noncontrolling interest     (2.1)     2.1
Comprehensive income (loss):            
Net income (loss) for the 52 weeks ended January 29, 2011, January 28, 2012 and 53 weeks ended February 2, 2013 (269.8)       (269.7) (0.1)
Foreign currency translation (5.4)     (5.3)   (0.1)
Total comprehensive income (loss) (275.2)          
Dividends [1] (102.5)       (102.5)  
Stock-based compensation 19.6   19.6      
Purchase of treasury stock (in shares)   (19.9)        
Purchase of treasury stock (409.4)   (409.4)      
Exercise of employee stock options and issuance of shares upon vesting of restricted stock grants (including tax benefit of $18.7, $2.1 and $2.0 for the 52 weeks ended January 29, 2011, January 28, 2012 and 53 weeks ended February 2, 2013 respectively) (in shares)   1.3        
Exercise of employee stock options and issuance of shares upon vesting of restricted stock grants (including tax benefit of $18.7, $2.1 and $2.0 for the 52 weeks ended January 29, 2011, January 28, 2012 and 53 weeks ended February 2, 2013 respectively) 13.6   13.6      
Balance at Feb. 02, 2013 $ 2,286.3 $ 0.1 $ 348.3 $ 164.4 $ 1,773.5  
Balance (in shares) at Feb. 02, 2013   118.2        
[1] Dividends declared per common share were $0.80 in the 53 weeks ended February 2, 2013.